USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Generics [UK] Limited

USPTO PatentsView assignee record - 12 granted patents across 4 technology areas, recorded in grant years 2015–2017. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Generics ranks #22,637 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 4 technology areas.

#22,637
of 49,997 US assignees by volume
20th percentile
by Innovation Score (26.3/100)
17.3
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R22637 · Foreign Corporation #22,637 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 12 grants
  • MID-PACK #22,637/49,997
  • PHOTO-FINISH Genemedicine
  • CPC-NARROW A61K · 4 areas
  • INNOV-THIN 26.3/100
  • CLAIMS-RICH 17.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Genemedicine Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Generics’s 26.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Generics

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Generics's Innovation Score is 26.3/100 (20th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Generics?

Each dot is one of Generics’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Generics’s own 17.3 claims/patent is ABOVE the 13.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Generics vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 11.911.91212.1 0510152025 Granted patents (volume) Avg claims / patent Genemedicine Co., Ltd. - 12, 7.25GenemedicineGeneral Dynamics-OTS, Inc. - 12, 16General Dynamics-…General LED, Inc. - 12, 4.75General LEDGeneral Vibration Corporation - 12, 20.25General VibrationGenpact USA, Inc. - 12, 20.33Genpact USAGeobra Brandstätter Stiftung & Co. KG - 12, 1Geobra Brandstätt…Giacomini S.p.A - 12, 13.42Giacomini S p AGilead Calistoga LLC - 12, 13.5Gilead CalistogaGenerics [UK] Limited - 12, 17.25Generics [UK]
Generics vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Generics's grants concentrate

Generics [UK] Limited is a focused PatentsView assignee: 4 CPC subclasses with 83.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2015 (8 grants) versus a trough of 1 in 2017. By volume, Generics sits between Genemedicine Co., Ltd. and Gilead Calistoga LLC.

Who files at Generics's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Generics holds 12 patents at rank #22,655, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Generics

By rank, the assignees closest to #22,655 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Generics's primary technology class.

Generics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 20th percentile higher than 20% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 201520162017 1
USPTO utility patent grants by year · 2015–2017

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Generics [UK] Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 8 66.7%
2016 3 25.0%
2017 1 8.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Generics [UK] Limited's patent record in context - here's where to go next.

  • Generics [UK] Limited's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 83.3% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #22,637 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Generics [UK] Limited against Genemedicine Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 26.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.